A Novel Adenovirus-Alphavirus Hybrid Vector
LI Ze-liang,WANG Hua,YANG Yue-feng,XIAO Feng-jun,LU Zhuo-zhuang,WANG Li-sheng
DOI: https://doi.org/10.3969/j.issn.1674-9960.2010.05.002
2010-01-01
Abstract:Objective To construct an adenovirus-alphavirus hybrid vector to enhance transgene expression in hematopoietic cells.Methods The main experimental procedure involved construction of the backbone and hybrid shuttle plasmids,rescue and propagation of the hybrid virus in packaging cells,and evaluation of gene transfer efficiency of the established vector.With the method of overlap extension PCR,E4 region of pAdEasy/F11p was partially deleted to generate the new backbone plasmid pAdEasy/F11pDE4orf3.Hematopoietic cell-specific promoter(CD11a promoter,CD11Ap),alphaviral vector elements(nsP),the target gene(GFP) and PolyA signal sequence(pA) were inserted in the multi-cloning site of pShuttle to construct the hybrid shuttle plasmid pSh-SFV-GFP.E.coli BJ5183 competent cells were co-transformed with pAdEasy/F11pDE4orf3 and linearized pSh-SFV-GFP to produce the hybrid virus plasmid pAd5/F11p-SFV-GFP by homologous recombination.Linearized pAd5/F11p-SFV-GFP was co-transfected to 293 cells with the helper virus plasmid pAd5/f11p-HV to rescue the hybrid virus Ad5/F11p-SFV-GFP.After being proliferated in 293 cells,Ad5/F11p-SFV-GFP was purified by CsCl density gradient centrifugation and then titrated.U937 cells were infected with Ad5/F11p-SFV-GFP or control Ad5-GFP viruses at a multiplicity of infection(MOI) of 100,and GFP expression was determined by flow cytometry assay 2 days post infection.Results pAdEasy-1/F11p-E4orf3 and pSh-SFV-GFP plasmids were confirmed by restriction enzyme digestion and sequencing.The hybrid virus was successfully rescued and purified,which reached a titer of 3×1010 IU/ml.GFP-positive cells were 55.79% or 2.42% for U937 cells infected by Ad5-GFP or Ad5/F11p-SFV-GFP,respectively.Conclusion Adenovirus-alphavirus hybrid vector is successfully constructed,which can facilitate further evaluation of gene transfer efficiency of the novel vector in hematopoietic cells.